Cleveland Clinic Mellen Center

Cleveland, Ohio 44195

0 studies enrolling now · 4 studies all time

What they study most

Multiple Sclerosis, Multiple Sclerosis (MS), Myasthenia Gravis, Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis, Relapsing-Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis

Studies at this site

• A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2) — Running, not enrolling
• A Study To Investigate The Pharmacokinetics, Safety, And Tolerability Of Subcutaneous Ocrelizumab Administration In Participants With Multiple Sclerosis — Completed
• ABA-101 in Participants With Progressive Multiple Sclerosis — Running, not enrolling
• Autologous Mesenchymal Stem Cell (MSC) Transplantation in MS — Completed